Feds Indict Former Bristol-Myers VP For Lying
This article was originally published in The Pink Sheet Daily
Andrew Bodnar allegedly misled FTC on generic Plavix deal with Apotex.
You may also be interested in...
Bristol will pay $1 million to close an investigation related to the renegotiation of a generic settlement with Apotex over Plavix.
Bristol estimates that “at risk” launch of generic clopidogrel impacted U.S. pharma sales by $525 mil. to $600 mil.
In a creative deal that echoes the strategic tie-up last year between Infinity and Mundipharma, Italian giant Chiesi Farmaceutici is buying a majority stake in Cornerstone Therapeutics, which gets $15.5 million along with U.S. rights for 10 years to Chiesi's marketed lung surfactant Curosurf